News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
705,357 Results
Type
Article (40283)
Company Profile (250)
Press Release (664823)
Multimedia
Podcasts (60)
Webinars (14)
Section
Business (204415)
Career Advice (2024)
Deals (35479)
Drug Delivery (95)
Drug Development (81258)
Employer Resources (173)
FDA (16284)
Job Trends (14910)
News (345818)
Policy (32660)
Tag
Academia (2560)
Accelerated approval (9)
Adcomms (22)
Allergies (96)
Alliances (49610)
ALS (108)
Alzheimer's disease (1446)
Antibody-drug conjugate (ADC) (153)
Approvals (16278)
Artificial intelligence (308)
Autoimmune disease (28)
Automation (18)
Bankruptcy (361)
Best Places to Work (11644)
BIOSECURE Act (19)
Biosimilars (122)
Biotechnology (175)
Bladder cancer (93)
Brain cancer (33)
Breast cancer (364)
Cancer (2863)
Cardiovascular disease (213)
Career advice (1691)
Career pathing (30)
CAR-T (185)
CDC (30)
Cell therapy (499)
Cervical cancer (22)
Clinical research (66933)
Collaboration (1013)
Company closure (3)
Compensation (686)
Complete response letters (23)
COVID-19 (2627)
CRISPR (56)
C-suite (326)
Cystic fibrosis (112)
Data (2993)
Decentralized trials (2)
Denatured (20)
Depression (60)
Diabetes (346)
Diagnostics (6426)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (138)
Drug pricing (121)
Drug shortages (28)
Duchenne muscular dystrophy (125)
Earnings (87456)
Editorial (40)
Employer branding (22)
Employer resources (149)
Events (113776)
Executive appointments (846)
FDA (17927)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (928)
Gene editing (129)
Generative AI (22)
Gene therapy (374)
GLP-1 (782)
Government (4510)
Grass and pollen (4)
Guidances (181)
Healthcare (18842)
Huntington's disease (30)
IgA nephropathy (39)
Immunology and inflammation (149)
Immuno-oncology (8)
Indications (39)
Infectious disease (2798)
Inflammatory bowel disease (148)
Inflation Reduction Act (10)
Influenza (62)
Intellectual property (119)
Interviews (317)
IPO (16599)
IRA (44)
Job creations (3652)
Job search strategy (1432)
Kidney cancer (13)
Labor market (52)
Layoffs (496)
Leadership (18)
Legal (7951)
Liver cancer (81)
Lung cancer (401)
Lymphoma (209)
Machine learning (11)
Management (58)
Manufacturing (383)
MASH (90)
Medical device (13461)
Medtech (13466)
Mergers & acquisitions (19592)
Metabolic disorders (849)
Multiple sclerosis (98)
NASH (16)
Neurodegenerative disease (116)
Neuropsychiatric disorders (33)
Neuroscience (2123)
NextGen: Class of 2025 (6525)
Non-profit (4491)
Now hiring (47)
Obesity (428)
Opinion (222)
Ovarian cancer (102)
Pain (105)
Pancreatic cancer (120)
Parkinson's disease (186)
Partnered (22)
Patents (296)
Patient recruitment (163)
Peanut (51)
People (57744)
Pharmaceutical (63)
Pharmacy benefit managers (21)
Phase I (20843)
Phase II (29473)
Phase III (21968)
Pipeline (1626)
Policy (199)
Postmarket research (2568)
Preclinical (8875)
Press Release (64)
Prostate cancer (139)
Psychedelics (36)
Radiopharmaceuticals (253)
Rare diseases (460)
Real estate (5925)
Recruiting (67)
Regulatory (22658)
Reports (50)
Research institute (2331)
Resumes & cover letters (351)
Rett syndrome (9)
RNA editing (8)
RSV (49)
Schizophrenia (86)
Series A (156)
Series B (108)
Service/supplier (11)
Sickle cell disease (60)
Special edition (18)
Spinal muscular atrophy (149)
Sponsored (32)
Startups (3593)
State (2)
Stomach cancer (14)
Supply chain (76)
Tariffs (57)
The Weekly (38)
Vaccines (780)
Venture capital (53)
Weight loss (257)
Women's health (47)
Worklife (16)
Date
Today (65)
Last 7 days (367)
Last 30 days (1867)
Last 365 days (31248)
2025 (16724)
2024 (35238)
2023 (40091)
2022 (51198)
2021 (55732)
2020 (54099)
2019 (46577)
2018 (35052)
2017 (32151)
2016 (31509)
2015 (37568)
2014 (31334)
2013 (26378)
2012 (28602)
2011 (29309)
2010 (27345)
Location
Africa (725)
Alabama (61)
Alaska (7)
Arizona (243)
Arkansas (13)
Asia (38243)
Australia (6248)
California (7427)
Canada (2355)
China (669)
Colorado (320)
Connecticut (318)
Delaware (192)
Europe (82203)
Florida (1115)
Georgia (247)
Hawaii (1)
Idaho (59)
Illinois (637)
India (26)
Indiana (361)
Iowa (16)
Japan (228)
Kansas (108)
Kentucky (29)
Louisiana (14)
Maine (64)
Maryland (1019)
Massachusetts (5517)
Michigan (246)
Minnesota (449)
Mississippi (3)
Missouri (89)
Montana (28)
Nebraska (25)
Nevada (80)
New Hampshire (66)
New Jersey (2070)
New Mexico (28)
New York (2082)
North Carolina (1078)
North Dakota (8)
Northern California (3270)
Ohio (235)
Oklahoma (16)
Oregon (34)
Pennsylvania (1609)
Puerto Rico (17)
Rhode Island (36)
South America (1101)
South Carolina (34)
South Dakota (1)
Southern California (2777)
Tennessee (126)
Texas (1122)
United States (27514)
Utah (219)
Virginia (184)
Washington D.C. (72)
Washington State (630)
West Virginia (4)
Wisconsin (66)
705,357 Results for "genentech inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Genentech Offers up to $765M in Biobucks to Repertoire for I&I Drug Discovery
Roche’s Genentech is betting on the Flagship Pioneering–founded company’s discovery platform called DECODE to find new targets for an undisclosed autoimmune disorder.
April 23, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
FDA Approves Genentech’s Susvimo for Diabetic Retinopathy
May 23, 2025
·
12 min read
Press Releases
Genentech’s Lunsumio and Polivy Combination Significantly Prolongs Remission for People With Relapsed or Refractory Large B-cell Lymphoma
June 23, 2025
·
19 min read
Press Releases
Genentech Provides Update on Phase III Verona Study
June 16, 2025
·
8 min read
Press Releases
Genentech’s Tecentriq Combined with Lurbinectedin Shows Significant Survival Benefit in Extensive-Stage Small Cell Lung Cancer
June 2, 2025
·
9 min read
Press Releases
New Data Show Genentech’s Itovebi Significantly Extended Survival in a Certain Type of HR-positive Advanced Breast Cancer
June 2, 2025
·
10 min read
Press Releases
Genentech’s Fenebrutinib Maintains Near-Complete Suppression of Disease Activity and Disability Progression for up to Two Years in People With Relapsing Multiple Sclerosis
May 30, 2025
·
15 min read
Press Releases
Genentech to Advance Prasinezumab Into Phase III Development for Early-Stage Parkinson’s Disease
June 16, 2025
·
5 min read
Press Releases
New Two-year Follow-up of Genentech’s Columvi Extends Overall Survival in Relapsed or Refractory Diffuse Large B-cell Lymphoma Patients
May 23, 2025
·
13 min read
Layoffs
Genentech Lays Off 143 Employees in South San Francisco Reshuffle
The downsizing comes after a year of workforce cuts and reorganization for Roche’s subsidiary.
June 11, 2025
·
1 min read
·
Dan Samorodnitsky
1 of 70,536
Next
